𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Absence of activating mutations in ras and gsp oncogenes in a cohort of nine patients with sporadic pediatric thyroid tumors

✍ Scribed by Pauws, Erwin ;Tummers, Rob F.H.M. ;Ris-Stalpers, Carrie ;de Vijlder, Jan J.M. ;Voûte, Tom


Publisher
John Wiley and Sons
Year
2001
Tongue
English
Weight
158 KB
Volume
36
Category
Article
ISSN
0098-1532

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Characterization of the genetic background of pediatric thyroid carcinomas could aid in distinguishing between differently staged tumors with respect to treatment and prognosis. Two known genetic factors associated with thyroid carcinoma, the proto‐oncogenes gsp and ras were investigated.

Procedure

DNA was extracted from paraffin sections from both tumor and normal thyroid tissue of nine patients (ages 9–16 years). Of these patients, eight were diagnosed with papillary carcinoma and one with follicular adenoma. The coding exons of gsp and the three known ras genes (H, K, and N‐ras) were screened for mutations using SSCP‐analysis.

Results

There were no mutations present in the ras and gsp proto‐oncogenes hot spots, however, LOH of H‐ras (chromosome location 11p15.5) was found in tumor tissue from one patient and a homozygous mutation in exon 12 of gsp causing a Pro→Ser conversion was present in the thyroid tumor tissue from another patient. Two silent polymorphisms were detected, H‐ras exon1, 86T→C and gsp exon 5, 81T→C.

Conclusions

Our results indicate that the ras/gsp mutations found are probably late events in the tumorigenesis representing general oncogenic stress. In conclusion, it seems that ras/gsp activation is not a factor in the mechanism causing sporadic thyroid carcinoma in children. Med. Pediatr. Oncol. 36:630–634, 2001. © 2001 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


High prevalence of BRAF mutation in a Br
✍ Gisele Oler; Janete M. Cerutti 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 166 KB 👁 1 views

## Abstract ## BACKGROUND: Although several studies undoubtedly demonstrated that __BRAF__ mutation is an important genetic event in the pathogenesis of papillary thyroid carcinoma (PTC), its prognostic significance and correlation with less differentiated states remains unclear. It has been sugge